Surmodics (SRDX)
(Delayed Data from NSDQ)
$38.20 USD
-0.17 (-0.44%)
Updated Oct 3, 2024 04:00 PM ET
After-Market: $38.21 +0.01 (0.03%) 4:50 PM ET
2-Buy of 5 2
C Value B Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for Surmodics, Inc falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -1.54 | -27.27 | 4.24 | 1.12 | 7.59 |
Depreciation/Amortization & Depletion | 8.89 | 9.14 | 8.02 | 7.26 | 7.57 |
Net Change from Assets/Liabilities | -4.24 | -11.95 | -4.86 | 1.12 | -9.95 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 7.40 | 12.86 | 7.99 | 4.51 | 2.82 |
Net Cash From Operating Activities | 10.51 | -17.22 | 15.39 | 14.01 | 8.04 |
Property & Equipment | -2.92 | -3.37 | -5.28 | -3.67 | -6.74 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | -40.55 | 0.00 | 0.00 |
Investments | -3.90 | 9.60 | 20.59 | -5.40 | 16.49 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -6.82 | 6.23 | -25.24 | -9.07 | 9.75 |
Uses of Funds
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.25 | 1.25 | 3.13 | 1.62 | -1.97 |
Issuance (Repayment) of Debt | 29.66 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | -10.00 | 0.00 | 10.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.51 | -1.62 | -2.90 | -6.26 | -9.06 |
Net Cash from Financing Activities | 18.41 | -0.38 | 10.23 | -4.65 | -11.03 |
Effect of Exchange Rate Changes | 0.32 | -0.79 | -0.01 | 0.13 | -0.07 |
Net Change In Cash & Equivalents | 22.42 | -12.16 | 0.37 | 0.42 | 6.69 |
Cash at Beginning of Period | 19.00 | 31.15 | 30.79 | 30.36 | 23.67 |
Cash at End of Period | 41.42 | 19.00 | 31.15 | 30.79 | 30.36 |
Diluted Net EPS | -0.11 | -1.96 | 0.30 | 0.08 | 0.55 |
Fiscal Year End for Surmodics, Inc falls in the month of September.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -8.09 | -0.54 | -0.79 | -1.54 | -8.23 |
Depreciation/Amortization & Depletion | 6.78 | 4.57 | 2.41 | 8.89 | 6.64 |
Net Change from Assets/Liabilities | -8.14 | -9.47 | -12.35 | -4.24 | 5.56 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 6.04 | 4.06 | 1.94 | 7.40 | 5.29 |
Net Cash From Operating Activities | -3.41 | -1.38 | -8.79 | 10.51 | 9.26 |
Property & Equipment | -2.95 | -1.99 | -0.72 | -2.92 | -2.17 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | -9.45 | -3.68 | -7.75 | -3.90 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -12.40 | -5.67 | -8.47 | -6.82 | -2.17 |
Uses of Funds
9/30/2024 | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 0.66 | 0.57 | 0.04 | 1.25 | 0.80 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 29.66 | 29.66 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | -10.00 | -10.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -2.05 | -2.02 | -1.09 | -2.51 | -2.48 |
Net Cash from Financing Activities | -1.39 | -1.45 | -1.05 | 18.41 | 17.99 |
Effect of Exchange Rate Changes | 0.08 | 0.12 | 0.25 | 0.32 | 0.50 |
Net Change In Cash & Equivalents | -17.12 | -8.39 | -18.06 | 22.42 | 25.58 |
Cash at Beginning of Period | 41.42 | 41.42 | 41.42 | 19.00 | 19.00 |
Cash at End of Period | 24.30 | 33.03 | 23.36 | 41.42 | 44.58 |
Diluted Net EPS | -0.53 | 0.02 | -0.06 | 0.48 | 0.52 |